Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALECTINIB Cause Blood creatine phosphokinase increased? 133 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Blood creatine phosphokinase increased have been filed in association with ALECTINIB (ALECENSA). This represents 1.5% of all adverse event reports for ALECTINIB.

133
Reports of Blood creatine phosphokinase increased with ALECTINIB
1.5%
of all ALECTINIB reports
1
Deaths
27
Hospitalizations

How Dangerous Is Blood creatine phosphokinase increased From ALECTINIB?

Of the 133 reports, 1 (0.8%) resulted in death, 27 (20.3%) required hospitalization, and 10 (7.5%) were considered life-threatening.

Is Blood creatine phosphokinase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 133 reports have been filed with the FAERS database.

What Other Side Effects Does ALECTINIB Cause?

Death (702) Fatigue (618) Constipation (525) Off label use (495) No adverse event (488) Disease progression (366) Rash (312) Dyspnoea (296) Drug ineffective (269) Myalgia (268)

What Other Drugs Cause Blood creatine phosphokinase increased?

ATORVASTATIN (1,491) SIMVASTATIN (895) ROSUVASTATIN (859) QUETIAPINE (663) CLOZAPINE (610) ARIPIPRAZOLE (594) OLANZAPINE (561) DAPTOMYCIN (461) RISPERIDONE (402) EZETIMIBE (350)

Which ALECTINIB Alternatives Have Lower Blood creatine phosphokinase increased Risk?

ALECTINIB vs ALEMTUZUMAB ALECTINIB vs ALENDRONATE ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL ALECTINIB vs ALENDRONIC ACID ALECTINIB vs ALEVE

Related Pages

ALECTINIB Full Profile All Blood creatine phosphokinase increased Reports All Drugs Causing Blood creatine phosphokinase increased ALECTINIB Demographics